DaVita Inc. (DVA) Dividend History

Company News

• Q1 Earnings Reveal Resilient S&P 500, but Consumer Cracks Are Emerging

  The Q1 2025 earnings season has seen mostly positive results from S&P 500 companies, with 78% beating Wall Street's expectations. However, some consumer-facing companies like Wynn, Clorox, and Restaurant Brands International reported weaker-than-anticipated profits and revenues, suggesting potential cracks in consumer spending.

  Investing.com

  Featured Companies: BIRK CAVA CLX DDS DIS FOX FOXA NRG PLTR QSR WMT WYNN
• Prediction: Warren Buffett Will Reveal an Increase in This Massive Berkshire Hathaway Holding on May 3

  The article predicts that Warren Buffett will reveal an increase in one of Berkshire Hathaway's biggest investment holdings during the company's upcoming annual shareholder meeting on May 3. It also discusses Buffett's recent stock purchases and the potential for individual investors to find value in smaller companies.

  The Motley Fool

  Featured Companies: BRK.A BRK.B OXY SIRI VRSN
• Wall Street Pulls Back After Early Gains As Tariff Uncertainties Persist: What's Driving Markets Monday?

  Wall Street pared early gains as investor caution returned despite a temporary easing in U.S.-China trade tensions. Tech stocks rallied premarket but lost momentum, while defensive sectors like real estate and utilities outperformed.

  Benzinga

  Featured Companies: AMZN CRL ENPH FSLR HUM LUV PLTR SNDK SPY UNH XLRE XLY
• YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities

  YMCA of the USA and DaVita, a leading kidney care provider, are expanding their collaboration to advance chronic disease education and prevention in seven communities across the country. The goal is to impact over 3,000 individuals by raising awareness of chronic kidney disease risk factors, providing screenings, and connecting communities with essential kidney health resources.

  GlobeNewswire Inc.
• Terumo (TRUMY) Unit's SOFAST Study Shows Positive Results - Zacks Investment Research

  Terumo's subsidiary MicroVention announced positive results from the SOFAST study, which evaluated the efficacy and safety of the SOFIA Flow Plus Aspiration Catheter in treating acute ischemic stroke. The study showed high rates of good functional outcomes and successful revascularization, setting a new standard for stroke thrombectomy devices.

  Zacks Investment Research

  Featured Companies: DXCM UHS